NCT03846310 A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer Status COMPLETED Phase PHASE1
NCT03842436 Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Status COMPLETED Phase PHASE4
NCT03820258 Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection Status TERMINATED Phase PHASE2
NCT03818308 Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir Status COMPLETED Phase PHASE2
NCT03794791 A Comprehensive HBsAg-positive Patients Centered Screening Strategy Status COMPLETED Phase N/A
NCT03772002 Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in Jiangsu Status UNKNOWN Phase NA
NCT03739866 Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults Status COMPLETED Phase PHASE1
NCT03725761 Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03701438 Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With Idelalisib Status TERMINATED Phase N/A
NCT03696290 Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis Status TERMINATED Phase PHASE4
NCT03693040 Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP) Status UNKNOWN Phase NA
NCT03639324 Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL Status WITHDRAWN Phase PHASE1
NCT03631732 Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants Status COMPLETED Phase PHASE3
NCT03628677 A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03615066 Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment Status COMPLETED Phase PHASE2